Cardiorentis competitors

Cardiorentis Competitors include Acticor Biotech, Global Blood Therapeutics, CTI BioPharma and Albireo Pharma.
Add company...
Cardiorentis
Cardiorentis
Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.
Acticor Biotech
Acticor Biotech
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
Global Blood Therapeutics
Global Blood Therapeutics
Global Blood Therapeutics (GBT) is dedicated to discovering, developing, and commercializing novel therapeutics to transform the treatment of patients with grievous blood-based disorders.
CTI BioPharma
CTI BioPharma
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
Albireo Pharma
Albireo Pharma
Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.
Founding Date
Founding Date
N/A
Founding Date
2013
Founding Date
2012
Founding Date
1992
Founding Date
2003
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Zug, CH HQ
Locations
Paris, FR HQ
Locations
South San Francisco, US HQ
Locations
Seattle, US HQ
Locations
Boston, US HQ
Employees
Employees
N/A
Employees
811% decrease
Employees
9573% increase
Employees
100
Employees
13
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2.4 b
Valuation ($)
93.9 m
Valuation ($)
426 m
Twitter followers
Twitter followers
N/A
Twitter followers
241
Twitter followers
N/A
Twitter followers
177
Twitter followers
91

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$25.1m (FY, 2017)
Revenue (est.)
$1k (FY, 2017)
Net income
Net income
N/A
Net income
N/A
Net income
($117m) (FY, 2017)
Net income
($45m) (FY, 2017)
Net income
($24.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 118.5m
Total funding raised
$ 25.6m
Total funding raised
$ 88.7m
Total funding raised
$ 85.1m
Total funding raised
$ 40m
For sources of this data, please see the company profileDownload Excel

View company profiles

Acticor Biotech
HQ
Paris, FR
Employees
8↓ 11% decrease

Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.

View company
Global Blood Therapeutics
HQ
South San Francisco, US
Employees
95

Global Blood Therapeutics (GBT) is dedicated to discovering, developing, and commercializing novel therapeutics to transform the treatment of patients with grievous blood-based disorders.

View company
CTI BioPharma
HQ
Seattle, US
Employees
100

CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.

View company
Albireo Pharma
HQ
Boston, US
Employees
13

Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.

View company